DORZOLAMIDE HYDROCHLORIDE TIMOLOL MALEATE (DORZOLAMIDE HYDROCHLORIDE TIMOLOL MALEATE) Nursing Considerations

What is the generic name?

DORZOLAMIDE HYDROCHLORIDE TIMOLOL MALEATE

What is the Trade Name for DORZOLAMIDE HYDROCHLORIDE TIMOLOL MALEATE?

DORZOLAMIDE HYDROCHLORIDE TIMOLOL MALEATE

What are the Indications for DORZOLAMIDE HYDROCHLORIDE TIMOLOL MALEATE?

• 1 INDICATIONS & USAGE Dorzolamide hydrochloride and timolol maleate ophthalmic solution, USP is indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension who are insufficiently responsive to beta-blockers (failed to achieve target IOP determined after multiple measurements over time). The IOP-lowering of dorzolamide hydrochloride and timolol maleate ophthalmic solution, USP administered twice a day was slightly less than that seen with the concomitant administration of 0.5% timolol administered twice a day and 2% dorzolamide administered three times a day [see Clinical Studies ( 14 )]. Dorzolamide hydrochloride and timolol maleate ophthalmic solution, USP is a combination of dorzolamide hydrochloride, a carbonic anhydrase inhibitor, and timolol maleate, a beta-adrenergic receptor blocking agent, indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension who are insufficiently responsive to beta-blockers. The IOP-lowering of dorzolamide hydrochloride and timolol maleate ophthalmic solution, USP twice daily was slightly less than that seen with the concomitant administration of 0.5% timolol twice daily, and 2% dorzolamide three times daily. ( 1 )

References: https://open.fda.gov/